First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: A population-based screening study (The FASTER Trial)

Lorraine Dugoff, John C. Hobbins, Fergal D. Malone, T. Flint Porter, David Luthy, Christine H. Comstock, Gary Hankins, Richard L. Berkowitz, Irwin Merkatz, Sabrina D. Craigo, Ilan E. Timor-Tritsch, Steven R. Carr, Honor M. Wolfe, John Vidaver, Mary E. D'Alton

Research output: Contribution to journalArticle

346 Citations (Scopus)

Abstract

The purpose of this study was to determine whether maternal serum levels of pregnancy-associated plasma protein A, free-beta subunit human chorionic gonadotropin, or nuchal translucency size are associated with obstetric complications. Data were obtained from the First and Second Trimester Evaluation of Risk trial. Pregnancy-associated plasma protein A and free-beta subunit human chorionic gonadotropin levels were analyzed, and nuchal translucency was measured between 10 weeks 3 days and 13 weeks 6 days of gestation in 34,271 pregnancies. Women with pregnancy-associated plasma protein A of ≤5th percentile were significantly more likely to experience spontaneous fetal loss at ≤24 weeks of gestation, low birth weight, preeclampsia, gestational hypertension, preterm birth (P <. 001) and stillbirth, preterm premature rupture of membranes, and placental abruption (P <. 02). Nuchal translucency at ≥99th percentile and free-beta subunit human chorionic gonadotropin at ≤1st percentile were associated with an increased risk of spontaneous loss at ≤24 weeks of gestation (adjusted odds ratios, 3.90, 3.62, respectively; P <. 001). Low pregnancy-associated plasma protein A levels in the first trimester were associated strongly with a number of adverse pregnancy outcomes. Low free-beta subunit human chorionic gonadotropin levels and large nuchal translucency were both associated with early fetal loss.

Original languageEnglish (US)
Pages (from-to)1446-1451
Number of pages6
JournalAmerican Journal of Obstetrics and Gynecology
Volume191
Issue number4
DOIs
StatePublished - Oct 2004

Fingerprint

Pregnancy-Associated Plasma Protein-A
Chorionic Gonadotropin, beta Subunit, Human
Nuchal Translucency Measurement
First Pregnancy Trimester
Obstetrics
Mothers
Pregnancy
Serum
Population
Abruptio Placentae
Pregnancy Induced Hypertension
Stillbirth
Premature Birth
Low Birth Weight Infant
Second Pregnancy Trimester
Pregnancy Outcome
Pre-Eclampsia
Odds Ratio

Keywords

  • Free-beta human chorionic gonadotropin
  • Nuchal translucency
  • Pregnancy-associated plasma protein A

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynecology

Cite this

First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications : A population-based screening study (The FASTER Trial). / Dugoff, Lorraine; Hobbins, John C.; Malone, Fergal D.; Porter, T. Flint; Luthy, David; Comstock, Christine H.; Hankins, Gary; Berkowitz, Richard L.; Merkatz, Irwin; Craigo, Sabrina D.; Timor-Tritsch, Ilan E.; Carr, Steven R.; Wolfe, Honor M.; Vidaver, John; D'Alton, Mary E.

In: American Journal of Obstetrics and Gynecology, Vol. 191, No. 4, 10.2004, p. 1446-1451.

Research output: Contribution to journalArticle

Dugoff, L, Hobbins, JC, Malone, FD, Porter, TF, Luthy, D, Comstock, CH, Hankins, G, Berkowitz, RL, Merkatz, I, Craigo, SD, Timor-Tritsch, IE, Carr, SR, Wolfe, HM, Vidaver, J & D'Alton, ME 2004, 'First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: A population-based screening study (The FASTER Trial)', American Journal of Obstetrics and Gynecology, vol. 191, no. 4, pp. 1446-1451. https://doi.org/10.1016/j.ajog.2004.06.052
Dugoff, Lorraine ; Hobbins, John C. ; Malone, Fergal D. ; Porter, T. Flint ; Luthy, David ; Comstock, Christine H. ; Hankins, Gary ; Berkowitz, Richard L. ; Merkatz, Irwin ; Craigo, Sabrina D. ; Timor-Tritsch, Ilan E. ; Carr, Steven R. ; Wolfe, Honor M. ; Vidaver, John ; D'Alton, Mary E. / First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications : A population-based screening study (The FASTER Trial). In: American Journal of Obstetrics and Gynecology. 2004 ; Vol. 191, No. 4. pp. 1446-1451.
@article{230a046b1490490b8bce62e17f6475ad,
title = "First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: A population-based screening study (The FASTER Trial)",
abstract = "The purpose of this study was to determine whether maternal serum levels of pregnancy-associated plasma protein A, free-beta subunit human chorionic gonadotropin, or nuchal translucency size are associated with obstetric complications. Data were obtained from the First and Second Trimester Evaluation of Risk trial. Pregnancy-associated plasma protein A and free-beta subunit human chorionic gonadotropin levels were analyzed, and nuchal translucency was measured between 10 weeks 3 days and 13 weeks 6 days of gestation in 34,271 pregnancies. Women with pregnancy-associated plasma protein A of ≤5th percentile were significantly more likely to experience spontaneous fetal loss at ≤24 weeks of gestation, low birth weight, preeclampsia, gestational hypertension, preterm birth (P <. 001) and stillbirth, preterm premature rupture of membranes, and placental abruption (P <. 02). Nuchal translucency at ≥99th percentile and free-beta subunit human chorionic gonadotropin at ≤1st percentile were associated with an increased risk of spontaneous loss at ≤24 weeks of gestation (adjusted odds ratios, 3.90, 3.62, respectively; P <. 001). Low pregnancy-associated plasma protein A levels in the first trimester were associated strongly with a number of adverse pregnancy outcomes. Low free-beta subunit human chorionic gonadotropin levels and large nuchal translucency were both associated with early fetal loss.",
keywords = "Free-beta human chorionic gonadotropin, Nuchal translucency, Pregnancy-associated plasma protein A",
author = "Lorraine Dugoff and Hobbins, {John C.} and Malone, {Fergal D.} and Porter, {T. Flint} and David Luthy and Comstock, {Christine H.} and Gary Hankins and Berkowitz, {Richard L.} and Irwin Merkatz and Craigo, {Sabrina D.} and Timor-Tritsch, {Ilan E.} and Carr, {Steven R.} and Wolfe, {Honor M.} and John Vidaver and D'Alton, {Mary E.}",
year = "2004",
month = "10",
doi = "10.1016/j.ajog.2004.06.052",
language = "English (US)",
volume = "191",
pages = "1446--1451",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "4",

}

TY - JOUR

T1 - First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications

T2 - A population-based screening study (The FASTER Trial)

AU - Dugoff, Lorraine

AU - Hobbins, John C.

AU - Malone, Fergal D.

AU - Porter, T. Flint

AU - Luthy, David

AU - Comstock, Christine H.

AU - Hankins, Gary

AU - Berkowitz, Richard L.

AU - Merkatz, Irwin

AU - Craigo, Sabrina D.

AU - Timor-Tritsch, Ilan E.

AU - Carr, Steven R.

AU - Wolfe, Honor M.

AU - Vidaver, John

AU - D'Alton, Mary E.

PY - 2004/10

Y1 - 2004/10

N2 - The purpose of this study was to determine whether maternal serum levels of pregnancy-associated plasma protein A, free-beta subunit human chorionic gonadotropin, or nuchal translucency size are associated with obstetric complications. Data were obtained from the First and Second Trimester Evaluation of Risk trial. Pregnancy-associated plasma protein A and free-beta subunit human chorionic gonadotropin levels were analyzed, and nuchal translucency was measured between 10 weeks 3 days and 13 weeks 6 days of gestation in 34,271 pregnancies. Women with pregnancy-associated plasma protein A of ≤5th percentile were significantly more likely to experience spontaneous fetal loss at ≤24 weeks of gestation, low birth weight, preeclampsia, gestational hypertension, preterm birth (P <. 001) and stillbirth, preterm premature rupture of membranes, and placental abruption (P <. 02). Nuchal translucency at ≥99th percentile and free-beta subunit human chorionic gonadotropin at ≤1st percentile were associated with an increased risk of spontaneous loss at ≤24 weeks of gestation (adjusted odds ratios, 3.90, 3.62, respectively; P <. 001). Low pregnancy-associated plasma protein A levels in the first trimester were associated strongly with a number of adverse pregnancy outcomes. Low free-beta subunit human chorionic gonadotropin levels and large nuchal translucency were both associated with early fetal loss.

AB - The purpose of this study was to determine whether maternal serum levels of pregnancy-associated plasma protein A, free-beta subunit human chorionic gonadotropin, or nuchal translucency size are associated with obstetric complications. Data were obtained from the First and Second Trimester Evaluation of Risk trial. Pregnancy-associated plasma protein A and free-beta subunit human chorionic gonadotropin levels were analyzed, and nuchal translucency was measured between 10 weeks 3 days and 13 weeks 6 days of gestation in 34,271 pregnancies. Women with pregnancy-associated plasma protein A of ≤5th percentile were significantly more likely to experience spontaneous fetal loss at ≤24 weeks of gestation, low birth weight, preeclampsia, gestational hypertension, preterm birth (P <. 001) and stillbirth, preterm premature rupture of membranes, and placental abruption (P <. 02). Nuchal translucency at ≥99th percentile and free-beta subunit human chorionic gonadotropin at ≤1st percentile were associated with an increased risk of spontaneous loss at ≤24 weeks of gestation (adjusted odds ratios, 3.90, 3.62, respectively; P <. 001). Low pregnancy-associated plasma protein A levels in the first trimester were associated strongly with a number of adverse pregnancy outcomes. Low free-beta subunit human chorionic gonadotropin levels and large nuchal translucency were both associated with early fetal loss.

KW - Free-beta human chorionic gonadotropin

KW - Nuchal translucency

KW - Pregnancy-associated plasma protein A

UR - http://www.scopus.com/inward/record.url?scp=7044251939&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=7044251939&partnerID=8YFLogxK

U2 - 10.1016/j.ajog.2004.06.052

DO - 10.1016/j.ajog.2004.06.052

M3 - Article

C2 - 15507981

AN - SCOPUS:7044251939

VL - 191

SP - 1446

EP - 1451

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 4

ER -